Tuberculosis, malaria and diseases caused by a diverse range of pathogens, including flaviviruses (eg dengue, West Nile), kinetoplastids (causative agents of Chagas disease, leishmaniasis, etc) and gut pathogens (worms, bacteria, parasites), remain a cause of high mortality across the globe. Fortunately, an ever-improving understanding of the complex life-cycles of these disease-causing pathogens is presenting increasing opportunities for those seeking to tackle these global health problems.
This meeting will focus on medicinal chemistry approaches to developing new medicines for diseases affecting global health. Keynote talks from international experts from industry and academia, alongside perspectives detailing case histories in drug discovery, will highlight the latest developments in the field whilst also showcasing the opportunity for creativity and innovation.
Bringing together leading exponents for an exciting spread of themed sessions, the meeting will appeal to anyone with an interest in drug discovery and medicinal chemistry. And with great opportunities for collaborative academic-industrial partnerships and open innovation drug discovery programmes, researchers from both sectors will benefit from the networking opportunities that the meeting will also offer.
For the current programme and list of confirmed speakers, please click here
Technology Park of Madrid, C / Severo Ochoa 2, 28760
Additional travel information may be found here.
Tel: +44 (0)1359 221004
Registration is now open. Further details can be found here
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
Read our event booking terms and conditions
Abstracts are invited for short oral presentations, and the closing date for abstract submission is Friday 24 April. An abstract template can be downloaded here.